mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.03 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.04 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.04 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.04 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.04 |